Drug application
WYAMINE SULFATE (MEPHENTERMINE SULFATE)
Drugs@FDA NDA 008248 · BAXTER HLTHCARE CORP
Key facts
| Drug name | WYAMINE SULFATE |
|---|---|
| Active ingredients | MEPHENTERMINE SULFATE |
| Application type | NDA |
| Application number | 008248 |
| Company | BAXTER HLTHCARE CORP |
| Dosage forms | INJECTABLE, INJECTION |
| Strength | EQ 30MG BASE/ML |
| Marketing status | Discontinued |
| Reference listed drug | No |
| Latest submission class | Type 3 - New Dosage Form |
| Latest submission status date | Dec 29, 1951 |
At a glance
- 1–9 Submissions
- 1–9 Supplements
- None Label versions
- 1–9 Products
- None Therapeutic equivalents
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA applications
Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.